News

Simcere Pharma said that through an acquisition made in September 2007, it currently holds a 51% stake in Boda. After the completion of the transaction with Xiangao, Simcere

As per the agreement, Scancell and ImmuneRegen are expected to work together to investigate the synergy between ImmuneRegen’s Homspera and Scancell’s ImmunoBody vaccine technologies. Scancell said that its

Management believes SOHM India’s manufacturing infrastructure is in place to grow sales of its private label generic pharmaceutical and nutraceutical product lines. Shailesh Shah, vice president for corporate

PTC Therapeutics claimed that Bmi-1 has been implicated in a wide variety of cancers and has been demonstrated to contribute to drug resistance and treatment failure. It acts

The analysis of the patient workup for the diagnosis of CHD demonstrated that the improved clinical accuracy of the HyperQ compared to standard stress testing can potentially lead

Launched under the brand name of Elder NRT, the product is a joint collaborative effort of Elder Pharma’s R&D division and Gelnova. Pastilles are hard jelly like preparation

Sprycel, an oral BCR-ABL inhibitor, is currently approved by the FDA for the treatment of adults for all phases of CML (chronic, accelerated, or myeloid or lymphoid blast

Keryx Biopharma has presented the data in the pediatric solid tumor poster discussion session held at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)

VBL claimed that VB-201 is the first in a new class of drugs and the lead candidate of several proprietary phospholipid analogs from its proprietary Lecinoxoid family that